| Item Type | Name |
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Drug Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Academic Article
|
Statin trials in progress: unanswered questions.
|
|
Academic Article
|
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Management of hypercholesterolaemia in postmenopausal women.
|
|
Academic Article
|
Combination therapy for dyslipidemia: safety and regulatory considerations.
|
|
Academic Article
|
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Combination lipid-lowering therapy in diabetes.
|
|
Academic Article
|
Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
|
|
Academic Article
|
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.
|
|
Academic Article
|
Ezetimibe: a novel option for lowering cholesterol.
|
|
Academic Article
|
Reducing residual risk for patients on statin therapy: the potential role of combination therapy.
|
|
Academic Article
|
Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
|
|
Academic Article
|
Statin safety: an assessment using an administrative claims database.
|
|
Academic Article
|
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
|
|
Academic Article
|
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
|
|
Academic Article
|
Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
|
|
Academic Article
|
Combination therapy in the management of complex dyslipidemias.
|
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
|
Academic Article
|
Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
|
|
Academic Article
|
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
|
|
Academic Article
|
Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
|
|
Academic Article
|
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
|
|
Academic Article
|
Safety of aggressive lipid management.
|
|
Academic Article
|
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
|
|
Academic Article
|
Statin and ezetimibe combination therapy in cardiovascular disease.
|
|
Academic Article
|
Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
|
|
Academic Article
|
One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
|
|
Academic Article
|
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
|
|
Academic Article
|
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
|
|
Academic Article
|
A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia.
|
|
Academic Article
|
Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu.
|
|
Academic Article
|
Safety considerations with fibrate therapy.
|
|
Academic Article
|
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
|
|
Academic Article
|
Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
|
|
Academic Article
|
Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
|
|
Academic Article
|
Separate and joint effects of marine oil and simvastatin in patients with combined hyperlipidemia.
|
|
Academic Article
|
Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.
|
|
Academic Article
|
Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
|
|
Academic Article
|
Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
|
|
Academic Article
|
Torcetrapib/atorvastatin combination therapy.
|
|
Academic Article
|
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
|
|
Academic Article
|
A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
|
|
Academic Article
|
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
|
|
Academic Article
|
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
|
|
Academic Article
|
Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Limitations of controlled augmentation trials in schizophrenia.
|
|
Academic Article
|
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
|
|
Academic Article
|
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.
|
|
Academic Article
|
Pharmacotherapy: Implications of high-dose statin link with incident diabetes.
|
|
Academic Article
|
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
|
|
Academic Article
|
Effect of spironolactone therapy on albuminuria in patients with type 2 diabetes treated with angiotensin-converting enzyme inhibitors.
|
|
Academic Article
|
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
|
|
Academic Article
|
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
|
|
Academic Article
|
Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
|
|
Academic Article
|
Combination therapy with statins: who benefits?
|
|
Academic Article
|
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.
|
|
Academic Article
|
A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.
|
|
Academic Article
|
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
|
|
Academic Article
|
A pilot study of clonidine plus physostigmine in Alzheimer's disease.
|
|
Academic Article
|
Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis.
|
|
Academic Article
|
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
|
|
Academic Article
|
LIMITATIONS IN THE USE OF ORAL HYPOGLYCEMIC AGENTS IN JUVENILE PATIENTS WITH DIABETES.
|
|
Academic Article
|
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
|
|
Academic Article
|
Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
|
|
Academic Article
|
Long-term safety of risperidone.
|
|
Academic Article
|
Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma.
|
|
Academic Article
|
Can We Cure Atherosclerosis?
|
|
Academic Article
|
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
|
|
Academic Article
|
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
|
|
Academic Article
|
Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients.
|
|
Academic Article
|
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
|
|
Academic Article
|
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.
|
|
Academic Article
|
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials.
|
|
Academic Article
|
A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients.
|
|
Academic Article
|
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
|
|
Academic Article
|
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
|